Integrated Diagnostics Holdings Plc

Integrated Diagnostics (IDHC)

[ADVERT]
Company name:Integrated Diagnostics Holdings Plc
EPIC:IDHCTrading Currency:USD
Market Sector:SMEVISIN:JE00BLKGSR75
Market Segment:SSMUShare Type:DE
WWW Address:http://www.idhcorp.com/Description:ORD USD0.25
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 1.29 images.advfn.com/imagesnew/2/gb/up 0.0075 [0.59] 1.28 1.29 1.27 1.27 1.27 3,942
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 192.89 150.11 0.00 4.72 23.60 27.23 18.37 3.91 - 0.90

Integrated Diagnostics Key Figures

(at previous day's close)
Market Cap.192.89m
Shares In Issue150.11m
Prev. Close1.28
PE Ratio27.23 
Dividend Yield18.37%
EPS - basic4.72¢($)
Dividend PS23.60¢($)
Dividend Cover- 
Cash Flow PS27.60¢($)
Return On Equity (ROE)26.17%
Operating Margin36.48%
PEG Factor-0.38 
EPS Growth Rate-70.97%
Dividends PS Growth Rate-%
Net Debt54.03m
Gross Gearing41.92%
Quick Assets46.17m
Net Working Capital3.49m
Intangibles / Fixed Assets65.11%
Turnover PS83.07¢($)
Pre-Tax Profit PS30.30¢($)
Retained Profit PS4.48¢($)
Cash PS18.77¢($)
Net Cash PS-12.80¢($)
Net Tangible Asset Value PS *7.99¢($)
Net Asset Value PS75.88¢($)
Spread0.01 (0.78%) 

Integrated Diagnostics Balance Sheet

L^IDHC:Liabilities+EQL^IDHC:Assets

Share Price Performance

Sample Period HighLow
1 week1.321.26
4 weeks1.321.21
12 weeks1.351.16
1 year3.910.90

Share Price Chart (5 years)

Integrated Diagnostics Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week1.32-0.04-2.651.260.041.28
4 weeks1.220.075.761.210.171.25
12 weeks1.240.043.631.160.181.24
26 weeks1.150.1412.231.100.201.20
1 year3.83-2.55-66.450.900.201.25
3 years3.75-2.47-65.730.900.122.54
5 years3.65-2.37-64.790.900.102.82

Integrated Diagnostics Key Management Ratios

Integrated Diagnostics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio7.23 
PE Ratio27.23 
Tobin's Q Ratio 0.05 
Tobin's Q Ratio (excl. intangibles)0.10 
Dividend Yield18.37%
Market-to-Book Ratio1.81 
Price-to-Pre-Tax Profit PS4.24 
Price-to-Retained Profit PS28.68 
Price-to-Cash Flow PS4.66 
Price-to-Sales PS1.55 
Price-to-Net Tangible Asset Value PS9.98 
Price-to-Cash PS6.85 
Net Working Capital PS2.33 
Price Pct to Working Capital PS55.26%
Earnings Yield3.67%
Average PE0.01 
Years in average5 
PE to PE average186,136.35%

Integrated Diagnostics Financial Ratios

(Leverage Ratios)
Debt Ratio23.41%
Debt-to-Equity Ratio0.31 
Debt-to-Equity Ratio (excl. Intgbl)1.80 
Debt-to-Equity Market Value0.18 
Net Gearing27.55%
Net Gearing (excl. Intangibles)53.21%
Gross Gearing41.92%
Gross Gearing (excl. Intangibles)80.96%
Gearing Under 1 Year24.16%
Gearing Under 1 Year (excl. Intgbl)46.67%
Assets/Equity1.72 
Cash/Equity24.73 
(Liquidity Ratios)
Net Working Capital to Total Assets1.78%
Current Ratio1.07 
Quick Ratio (Acid Test)0.97 
Liquidity Ratio0.59 
Cash & Equiv/Current Assets55.38%
(Solvency Ratios)
Enterprise Value206.88m
CFO/Sales0.33 
CFO/Attributable Profit1.49 
CFO/Assets0.21 
CFO/Debt0.50 
Total Debt/Equity Market Value0.43 
Total Debt/Sales0.66 
Total Debt/Pre-Tax Profit1.81 
Total Debt82.20m
Total Debt/Net Current Assets23.55%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs1 
Beta (60-Mnth)Beta (36-Mnth)
0.0004-0.0004

Integrated Diagnostics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)30.59%
Return On Assets (ROA)0.70%
Net Profit Margin22.36%
Assets Turnover0.03 
Return On Equity (ROE)26.17%
Return On Investment (ROI)0.91%
Dividend Payout Ratio507.82%
Plowback Ratio-407.82%
Growth from Plowback Ratio-5.07%
Net Income Of Revenues5.39%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.06 
Fixed Assets Turnover0.04 
Current Assets Turnover0.13 
Net Working Capital Turnover 
Inventory Turnover1.35 
(Other Operating Ratios)
Total Assets-to-Sales31.81 
Debtors-to-Sales283.21%
Debt Collection Period1,033.72Days

Integrated Diagnostics Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
17 Jun 2020FinalUSX4.9031/12/201931/12/202008/07/202109/07/202129/07/202123.60
02 Sep 2020InterimUSX18.7030/12/201930/06/202010/09/202011/09/202002/10/2020-

Integrated Diagnostics Fundamentals

 31 Dec 2017 (EGP)31 Dec 2018 (EGP)31 Dec 2019 (EGP)31 Dec 2020 (EGP)
turnover1,514.26100.00%1,921.45100.00%2,226.49100.00%2,656.26100.00%m
pre tax profit558.4336.88%717.3637.33%758.1434.05%969.0836.48%m
attributable profit374.0224.70%502.0926.13%510.9322.95%594.0122.36%m
retained profit-2.72-0.18%67.143.49%60.432.71%143.285.39%m
eps - basic249.00 335.00 341.00 99.00 
eps - diluted249.00 335.00 341.00 99.00 
dividends per share- - - 23.60 

Integrated Diagnostics Balance Sheet

 31 Dec 2017 (EGP)31 Dec 2018 (EGP)31 Dec 2019 (EGP)31 Dec 2020 (EGP)
L^IDHC:Liabilities+EQL^IDHC:AssetsL^IDHC:Liabilities+EQL^IDHC:AssetsL^IDHC:Liabilities+EQL^IDHC:AssetsL^IDHC:Liabilities+EQL^IDHC:Assets
 31 Dec 2017 (EGP)31 Dec 2018 (EGP)31 Dec 2019 (EGP)31 Dec 2020 (EGP)
ASSETS
fixed assets fixed assets473.7915.23%705.7820.55%785.5520.92%793.0118.98%m
intangibles intangibles1,658.2553.29%1,672.4648.71%1,925.6051.27%2,014.4448.22%m
fixed investments fixed investments9.150.29%239.906.99%228.016.07%286.236.85%m
current assets - other current assets - other--%--%--%--%m
stocks stocks69.942.25%91.082.65%84.342.25%100.122.40%m
debtors debtors202.266.50%299.998.74%322.808.60%383.489.18%m
cash & securities cash & securities698.4422.44%424.5712.36%409.1410.89%600.1314.37%m
TOTAL3,111.81100%3,433.79100%3,755.44100%4,177.41100%m
LIABILITIES
creditors - short creditors - short485.4115.60%669.3219.49%828.2222.05%1,009.3624.16%m
creditors - long creditors - long312.3110.04%363.8310.60%566.9615.10%741.6717.75%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL797.7225.64%1,033.1530.09%1,395.1837.15%1,751.0441.92%m
EQUITY
ord cap, reserves ord cap, reserves2,245.5972.16%2,270.0566.11%2,215.5559.00%2,269.9954.34%m
prefs, minorities prefs, minorities68.502.20%130.593.80%144.713.85%156.383.74%m
TOTAL2,314.0974.36%2,400.6469.91%2,360.2662.85%2,426.3758.08%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Integrated Diagnostics Cash Flow Statement

31 Dec 2017 (EGP)31 Dec 2018 (EGP)31 Dec 2019 (EGP)31 Dec 2020 (EGP)
Operating CF403.08556.31697.41882.52m
Pre-Financing CF369.1890.69561.06758.25m
Retained CF-1.64-268.0412.33194.71m

Integrated Diagnostics Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
LSE
IDHC
Integrated..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20211128 22:11:19